Pre-listing trading for JIANGXI BIO (06915), which is scheduled to list on the Hong Kong exchange on Tuesday, June 30th, has commenced.
As of the latest update, the indicative price in the pre-market session is HK$10. This represents a decline of 10.71% from its initial public offering price of HK$11.2 per share.
Based on a board lot size of 500 shares and excluding transaction fees, this price movement translates to a loss of HK$600 per board lot.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.